Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Juvaris BioTherapeutics Announces Award of U01 Cooperative Research Partnership From Niaid
August 14th, 2007
Juvaris BioTherapeutics, Inc. announced that it has been awarded an estimated $9 million, 5-year grant by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop adjuvants for influenza vaccines. This research will be conducted in collaboration with Dr. David Lewis of Stanford University and Dr. Chris Miller of the National Primate Research Center at the University of California, Davis. The results obtained from research carried out under this cooperative partnership will also be applicable to other viral, bacterial and cancer vaccines using the JuvaVax(TM) adjuvant technology currently in development at Juvaris....
Source: Virus Weekly (2007-08-14)
|
